Andrew M. Evens, DO, MSc, MBA
Chair, Scientific Advisory Board
Rutgers Cancer Institute of New Jersey
RWJBarnabas Health

Dr. Evens is the Deputy Director for Clinical Services of the Rutgers Cancer Institute and Chief Physician Officer of the new freestanding Jack & Sheryl Morris Cancer Center and Hospital; System Director of Medical Oncology and Oncology Lead for the Combined Medical Group with RWJBarnabas Health (RWJBH); and Associate Vice Chancellor for Clinical Innovation and Data Analytics within Rutgers Health at Rutgers University. A distinguished clinical investigator specializing in Hodgkin lymphoma and varied forms of non-Hodgkin lymphoma, his research interests include adolescent and young adult (AYA) lymphoma, discovery and examination of novel therapeutic agents, prognostication and predictive modeling, big data, and patient health outcomes.

A member of the SAB since 2014, Dr. Evens also contributes to multiple prestigious organizations, including the Hodgkin Lymphoma Working Group for the NIH/NCI Steering Committee, the ECOG-ACRIN Lymphoma Committee, the Big 10 Cancer Research Consortium lymphoma working group, and he is vice chair for the ASH Research Council Board of Directors. Additionally, he was the founding Editor-in-Chief of the gold open-access journal eJHaem, and he is the current Editor-in-Chief for the British Journal of Haematology.